PLEKHM2
Basic information
Region (hg38): 1:15684320-15734769
Links
Phenotypes
GenCC
Source:
- dilated cardiomyopathy (Limited), mode of inheritance: AR
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PLEKHM2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 182 | 12 | 198 | |||
missense | 352 | 10 | 369 | |||
nonsense | 3 | |||||
start loss | 0 | |||||
frameshift | 8 | |||||
inframe indel | 8 | |||||
splice donor/acceptor (+/-2bp) | 3 | |||||
splice region | 11 | 21 | 8 | 40 | ||
non coding | 79 | 47 | 129 | |||
Total | 0 | 0 | 381 | 268 | 69 |
Variants in PLEKHM2
This is a list of pathogenic ClinVar variants found in the PLEKHM2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-15684398-C-T | Benign (Jun 01, 2021) | |||
1-15684510-G-GGGC | Benign (Apr 03, 2021) | |||
1-15684564-G-A | Dilated Cardiomyopathy, Recessive | Likely benign (Aug 09, 2022) | ||
1-15684566-C-T | Dilated Cardiomyopathy, Recessive • not specified | Uncertain significance (Nov 02, 2023) | ||
1-15684572-A-T | Dilated Cardiomyopathy, Recessive | Uncertain significance (Mar 19, 2022) | ||
1-15684580-G-A | Dilated Cardiomyopathy, Recessive | Uncertain significance (Nov 24, 2023) | ||
1-15684583-C-G | Dilated Cardiomyopathy, Recessive | Uncertain significance (Dec 17, 2021) | ||
1-15684588-C-T | Dilated Cardiomyopathy, Recessive | Likely benign (May 27, 2022) | ||
1-15684608-C-T | Dilated Cardiomyopathy, Recessive | Uncertain significance (Jul 05, 2022) | ||
1-15684609-G-A | Dilated Cardiomyopathy, Recessive | Likely benign (Jan 09, 2024) | ||
1-15684611-TGAA-T | Dilated Cardiomyopathy, Recessive | Uncertain significance (Apr 23, 2022) | ||
1-15684632-C-T | Dilated Cardiomyopathy, Recessive | Likely benign (Jan 08, 2024) | ||
1-15684636-C-T | Dilated Cardiomyopathy, Recessive | Likely benign (Sep 14, 2022) | ||
1-15684697-G-GGCGACCCTGCTGCCGCAGGGACTC | Benign (Aug 03, 2020) | |||
1-15715894-T-C | Benign (Oct 30, 2018) | |||
1-15716217-G-GGT | Dilated Cardiomyopathy, Recessive | Likely benign (Dec 09, 2023) | ||
1-15716219-T-C | Dilated Cardiomyopathy, Recessive | Likely benign (Sep 08, 2021) | ||
1-15716220-G-C | Dilated Cardiomyopathy, Recessive | Likely benign (Sep 22, 2023) | ||
1-15716220-GT-G | Dilated Cardiomyopathy, Recessive | Benign (Sep 18, 2023) | ||
1-15716220-G-GT | Dilated Cardiomyopathy, Recessive | Benign (Jun 19, 2023) | ||
1-15716221-T-G | Dilated Cardiomyopathy, Recessive | Likely benign (Jan 12, 2024) | ||
1-15716222-T-G | Dilated Cardiomyopathy, Recessive | Likely benign (Apr 26, 2022) | ||
1-15716227-T-C | Dilated Cardiomyopathy, Recessive | Likely benign (Jul 24, 2020) | ||
1-15716228-TTC-T | Dilated Cardiomyopathy, Recessive | Benign (Jan 31, 2024) | ||
1-15716229-TC-T | Dilated Cardiomyopathy, Recessive | Benign (Jan 31, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PLEKHM2 | protein_coding | protein_coding | ENST00000375799 | 20 | 50438 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000171 | 1.00 | 124661 | 0 | 23 | 124684 | 0.0000922 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.00 | 467 | 606 | 0.771 | 0.0000382 | 6513 |
Missense in Polyphen | 130 | 188.76 | 0.68869 | 2055 | ||
Synonymous | -0.0573 | 270 | 269 | 1.00 | 0.0000192 | 1985 |
Loss of Function | 4.07 | 17 | 47.2 | 0.360 | 0.00000233 | 543 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000152 | 0.000152 |
Ashkenazi Jewish | 0.000203 | 0.000199 |
East Asian | 0.000228 | 0.000222 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000912 | 0.0000884 |
Middle Eastern | 0.000228 | 0.000222 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.000184 | 0.000165 |
dbNSFP
Source:
- Function
- FUNCTION: May play a role in the regulation of conventional kinesin activity. Required for maintenance of the Golgi apparatus organization. May play a role in membrane tubulation (PubMed:15905402). May play a role in lysosomes movement and localization at the cell periphery (PubMed:25898167). {ECO:0000269|PubMed:15905402, ECO:0000269|PubMed:25898167}.;
- Pathway
- Salmonella infection - Homo sapiens (human)
(Consensus)
Recessive Scores
- pRec
- 0.109
Intolerance Scores
- loftool
- 0.449
- rvis_EVS
- -0.57
- rvis_percentile_EVS
- 19.01
Haploinsufficiency Scores
- pHI
- 0.219
- hipred
- N
- hipred_score
- 0.414
- ghis
- 0.519
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.375
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Plekhm2
- Phenotype
- growth/size/body region phenotype; homeostasis/metabolism phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); immune system phenotype;
Gene ontology
- Biological process
- Golgi organization;lysosome localization;regulation of protein localization;positive regulation of membrane tubulation
- Cellular component
- endosome membrane
- Molecular function
- protein binding;kinesin binding